Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:987 (24 April), doi:10.1136/bmj.38055.451968.55 (published 17 March 2004)
Paul Roderick, senior lecturer in public health1
1 Community Clinical Sciences Research Division, University of Southampton, B Floor, South Academic Block, Southampton General Hospital, Southampton SO16 6YD
Correspondence to: P Roderick pjr@soton.ac.uk
| The first 150 words of the full text of this article appear below. |
Chronic liver disease and hepatocellular carcinoma are major worldwide public health problems in countries with endemically high levels of viral hepatitis (B and C).1 However, even in western countries chronic liver disease is an emerging problem, due not only to viral hepatitis but also to the effects of lifestyle factors such as heavy alcohol consumption and obesity.2 3
Liver function tests are widely performed blood tests used in patients with suspected liver disease or unexplained illness and in some specific situations such as screening of blood donors. The most widely used tests are those used to detect the aminotransferasesalanine and aspartatewhich are associated with hepatocellular injury. Raised concentrations may indicate serious underlying chronic liver disease, recognition of which is important for guiding interventions to modify lifestyle and use of specific therapies such as interferon for hepatitis C to prevent the risk of progression to cirrhosis.
The sensitivity, specificity, and predictive values
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?